Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC011227 | Panoply™ Human PABPC5 Knockdown Stable Cell Line | Inquiry |
| CSC-SC011227 | Panoply™ Human PABPC5 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD11735Z | Human PABPC5 adenoviral particles | Inquiry |
| LV20857L | human PABPC5 (NM_080832) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH369808 | shRNA set against Mouse PABPC5 (NM_053114.2) | Inquiry |
| SHH369804 | shRNA set against Human PABPC5 (NM_080832.2) | Inquiry |
| SHH369812 | shRNA set against Rat PABPC5 (NM_001110366.2) | Inquiry |
| SHR077172 | shRNA set against Mouse Pabpc5(NM_053114.2) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| MiUTR1M-08852 | PABPC5 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-02745 | PABPC5 miRNA 3'UTR clone | Inquiry |
| CDCB187531 | Rabbit PABPC5 ORF clone (XM_002720153.2) | Inquiry |
| CDCR264341 | Mouse Pabpc5 ORF Clone(NM_053114.2) | Inquiry |
| CDCR376301 | Rat Pabpc5 ORF Clone(NM_001110366.2) | Inquiry |
| CDCS416687 | Human PABPC5 ORF Clone (BC063113) | Inquiry |
PABPC5 gene is mapped to X-specific sub-interval in the Xq21.3/Yp11.2 Homology block of the human sex chromosomes
The isolation and characterization of poly(A)-binding protein gene, PABPC5, which is located in the X-specific 13d-sY43 sub-interval of the Xq21.3/Yp11.2 homology block has been reported. Determination of its structure and pattern, or refinement of the physical mapping of the region on the X and corresponding segment on the Y, have shown that there is highly conservation of PABPC5 in primates and rodents but without a conserved homologous counterpart on the human Y chromosome.
The novel gene PABPC5 has been described with the characterization of derivation from X-specific sub-interval and belonging to the poly(A)-binding protein gene family. Its genomic structure has coverage of 4061 bp of an uninterrupted open reading frame (ORF) and a 5' UTR spanning across two exons and associated with a CpG island. In addition to this, 4 RNA recognition motif domains were contained within the potential 382-amino-acid protein. PABPC5 has 73% nucleotide identity with PABPC4 over 1802 bp of the ORF and share60 identity and 73% similarity with human PABPC4, as well as Xenopus PABPC1. Expression of PABPC5 can be seen in fetal brain and in a range of adult tissues by the RT-PCR assays.
Regulation on vasculogenic mimicry of glioma by PABPC5/HCG15/ZNF331 feedback loop initiated STAU1-mediated mRNA decay
PABPC5 (poly(A) binding protein cytoplasmic 5), located on chromosome Xq21.3/Yp11.2 as a member of the cytosolic poly(A) binding protein family, can binds to the protein at the 3' end of the poly(A) rail of most eukaryotic mRNAs, and it was found to be involved in DNA and RNA metabolism in mitochondria. Due to its location on translocation breakpoint DX214 and association with premature ovarian failure in ovarian disease, high expression of PABPC5 has been confirmed to be closely related to poor prognosis of ovarian cancer patients. And in accorded with the concept of vasculogenic mimicry (VM) was firstly proposed by Maniotis in the study of melanoma, where can see vascular channels independent from endothelial cells generated tumor cells, anti-VM can be listed as a new strategy for glioma treatment, for which vasculogenic mimicry (VM) work as one of the blood supply methods, is the most common primary malignancy in the brain. Although active treatment, such as surgery, radiation therapy, and chemotherapy can improve the symptoms of glioma, there are still a high recurrence rate and low average median survival time. And vascular mimicry-related genes and signal transduction resorted pathways, such as feedback loop of PABPC5/HCG15/ZNF331 in glioma cell lines and role of them in regulating glioma VM will provide new molecular mechanisms for glioma development.
Figure 1. PABPC5, HCG15, and ZNF331 involved new molecular mechanisms for glioma development. (Fangkun Jing, et al. 2020)
References: